InvestSMART

Osteopore Limited (ASX: OSX) - Announcements

- Current share price for OSX : $0.004

ASX company news and announcements for Osteopore Limited (OSX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Osteopore Limited (OSX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Osteopore Limited (OSX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Osteopore Limited (OSX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$3 Activities Update Qtr Ending September 2023 and Appendix 4C 31 Oct 2023 8:15AM $0.052 $0.004 fallen by 92.31%
$3 Change of Director's Interest Notice 5 Oct 2023 7:31PM $0.054 $0.004 fallen by 92.59%
$3 Clarification Announcement 18 Sep 2023 11:25AM $0.062 $0.004 fallen by 93.55%
$3 Investor Webinar Presentation 18 Sep 2023 8:58AM $0.069 $0.004 fallen by 94.20%
$3 MOU with Temasek-linked Innoventures - Orthopaedics in China 12 Sep 2023 8:20AM $0.069 $0.004 fallen by 94.20%
$3 Resignation of Joint Company Secretary 4 Sep 2023 5:38PM $0.068 $0.004 fallen by 94.12%
$3 Half Yearly Report and Accounts 31 Aug 2023 5:29PM $0.072 $0.004 fallen by 94.44%
$3 Timeline extended for definitive agreements with CellHeal 29 Aug 2023 7:06PM $0.070 $0.004 fallen by 94.29%
$3 Notification of cessation of securities - OSX 28 Aug 2023 6:13PM $0.070 $0.004 fallen by 94.29%
$3 Clarification Announcement 1 Aug 2023 4:13PM $0.077 $0.004 fallen by 94.81%
$3 Investor Presentation 1 Aug 2023 10:34AM $0.077 $0.004 fallen by 94.81%
$3 Initial Director's Interest Notice - MK 31 Jul 2023 4:38PM $0.077 $0.004 fallen by 94.81%
$3 Activities Update Qtr Ending June 2023 and Appendix 4C 31 Jul 2023 8:46AM $0.077 $0.004 fallen by 94.81%
$3 OSX receives A$10m commitment for commercialisation in China 25 Jul 2023 8:41AM $0.080 $0.004 fallen by 95%
$3 Osteopore strengthens Board & Management by key appointments 18 Jul 2023 8:42AM $0.079 $0.004 fallen by 94.94%
$3 Change of Director's Interest Notice - ML 7 Jul 2023 6:33PM $0.082 $0.004 fallen by 95.12%
$3 Rectification of Breach of ASX Listing Rule 10.11 7 Jul 2023 5:16PM $0.082 $0.004 fallen by 95.12%
$3 Application for quotation of securities - OSX 29 Jun 2023 3:14PM $0.084 $0.004 fallen by 95.24%
$3 Notice of Breach of ASX Listing Rule 10.11 26 Jun 2023 6:21PM $0.105 $0.004 fallen by 96.19%
$3 Change of Share Registry Details 23 Jun 2023 4:38PM $0.115 $0.004 fallen by 96.52%
$3 Shortfall oversubscribed for Osteopore's Global Expansion 20 Jun 2023 8:45AM $0.110 $0.004 fallen by 96.36%
$3 Strategic Partnership for Clinical R&D in China worth $4M 8 Jun 2023 8:54AM $0.084 $0.004 fallen by 95.24%
$3 Results of Annual General Meeting 30 May 2023 5:45PM $0.079 $0.004 fallen by 94.94%
$3 Notification regarding unquoted securities - OSX 25 May 2023 6:38PM $0.078 $0.004 fallen by 94.87%
$3 Largest South African Medical Insurer provides cover for OSX 16 May 2023 8:19AM $0.076 $0.004 fallen by 94.74%

301 - 325 of 518 results

Page 13 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.